272
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis

, FRCS, MMed, , MD, , MD, PhD, , FRCOphth, , FRCOphth & , FRCOphth
Pages 35-42 | Received 01 Jan 2015, Accepted 18 Mar 2015, Published online: 26 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Anahita Kate & Sayan Basu. (2022) Systemic Immunosuppression in Cornea and Ocular Surface Disorders: A Ready Reckoner for Ophthalmologists. Seminars in Ophthalmology 37:3, pages 330-344.
Read now
Giuseppe Giannaccare, Alessandro Finzi, Stefano Sebastiani, Fedele Greco, Piera Versura & Emilio C. Campos. (2018) The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery. Current Eye Research 43:12, pages 1445-1453.
Read now
Emmett T. Cunningham$suffix/text()$suffix/text(), Peter McCluskey, Carlos Pavesio, Denis Wakefield & Manfred Zierhut. (2016) Scleritis. Ocular Immunology and Inflammation 24:1, pages 2-5.
Read now

Articles from other publishers (20)

Keisuke Hoshi, Hiroshi Kunikata, Naoko Aizawa, Masayuki Yasuda, Tatsu Okabe, Hiroki Takizawa, Toshiaki Abe & Toru Nakazawa. (2023) Baseline characteristics associated with the incidence of intraocular inflammation after the intravitreous injection of brolucizumab. International Ophthalmology.
Crossref
Lilla Smeller, Edit Toth-Molnar & Nicolette Sohar. (2023) Optical Coherence Tomography: Focus on the Pathology of Macula in Scleritis Patients. Journal of Clinical Medicine 12:14, pages 4825.
Crossref
Minna Karesvuo, Sam Häyry, Petteri Karesvuo, Piotr Kanclerz & Raimo Tuuminen. (2022) Association between periodontitis and blood-ocular barrier disruption. European Journal of Ophthalmology 33:3, pages 1473-1479.
Crossref
Ferhat Turgut, Vita Dingerkus, Christoph Tappeiner & Matthias Becker. (2023) Diagnostisches und therapeutisches Management der Episkleritis und Skleritis. Klinische Monatsblätter für Augenheilkunde 240:05, pages 725-738.
Crossref
Donghao Gu, Hao Pan, Shuo Xu, Wenyue Chen, Renfang Zhu, Wenjing Jiang & Weisan Pan. (2022) Construction and Evaluation of Hyaluronic Acid–Coated Flurbiprofen-Layered Double Hydroxide Ocular Drug Delivery System. AAPS PharmSciTech 23:8.
Crossref
Murat Hasanreisoglu, Cem Kesim, Duygu Yalinbas, Mervenur Yilmaz, Nur Sena Uzunay, Zeynep Aktas, Muhammad Sohail Halim, Yasir J Sepah, Quan Dong Nguyen & Afsun Sahin. (2021) Effect of light backscattering from anterior segment structures on automated flare meter measurements. European Journal of Ophthalmology 32:4, pages 2291-2297.
Crossref
Paulina Liberman, Bryn M. Burkholder, Jennifer E. Thorne & Meghan K. Berkenstock. (2022) Effectiveness of Difluprednate for the Treatment of Anterior Scleritis. American Journal of Ophthalmology 235, pages 172-177.
Crossref
Nengli Yang, Yafeng Liang, Pei Yang & Liuming Jiang. (2022) Flurbiprofen inhibits cell proliferation in thyroid cancer through interrupting HIP1R-induced endocytosis of PTEN. European Journal of Medical Research 27:1.
Crossref
Ahmad Abdel-Aty, Akash Gupta, Lucian Del Priore & Ninani Kombo. (2022) Management of noninfectious scleritis. Therapeutic Advances in Ophthalmology 14, pages 251584142110708.
Crossref
Elçin Bakır, Tuğbagül Çal, Sevtap Aydın Dilsiz, Hande Canpınar, Ayşe Eken & Ülkü Ündeğer Bucurgat. (2021) Assessment of the cytotoxic, genotoxic, and apoptotic potential of flurbiprofen in HeLa and HepG2 cell lines. Journal of Biochemical and Molecular Toxicology 35:6, pages 1-11.
Crossref
Alessandro Conforti, Ilenia Di Cola, Viktoriya Pavlych, Piero Ruscitti, Onorina Berardicurti, Francesco Ursini, Roberto Giacomelli & Paola Cipriani. (2021) Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmunity Reviews 20:2, pages 102735.
Crossref
Sathana Ingaralingam, Saaeha Rauz, Philip I. Murray & Robert J. Barry. (2020) Effectiveness of pharmacological agents for the treatment of non-infectious scleritis: a systematic review protocol. Systematic Reviews 9:1.
Crossref
Mingyang Sun, Xuhui Cong, Enqiang Chang, Mengrong Miao & Jiaqiang Zhang. (2020) Efficacy of Flurbiprofen for Postoperative Pain in Chinese Surgical Patients: A Meta-Analysis. Journal of Surgical Research 252, pages 80-88.
Crossref
CheSuraya Zin, NorzainiRos Nozid, AmaliaAthirah Razak, SitiNuraisyah Hashim, NurAimi Mazlan, Norhayati Daud & SitiHalimah Bux. (2020) Research on nonsteroidal anti-inflammatory drugs in Malaysia: A bibliometric analysis. Journal of Pharmacy And Bioallied Sciences 12:6, pages 707.
Crossref
Parteek Prasher, Harish Mudila, Mousmee Sharma & Beena Khati. (2019) Developmental perspectives of the drugs targeting enzyme-instigated inflammation: a mini review. Medicinal Chemistry Research 28:4, pages 417-449.
Crossref
P. Sève, L. Kodjikian & Y. Jamilloux. (2018) Manifestations ophtalmologiques de la sarcoïdose : que doit savoir l’interniste ?. La Revue de Médecine Interne 39:9, pages 728-737.
Crossref
Carl P. Herbort & Ilknur Tugal-Tutkun. (2016) The importance of quantitative measurement methods for uveitis: laser flare photometry endorsed in Europe while neglected in Japan where the technology measuring quantitatively intraocular inflammation was developed. International Ophthalmology 37:3, pages 469-473.
Crossref
Maxwell S. StemBozho TodorichLisa J. Faia. (2017) Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective. Journal of Ocular Pharmacology and Therapeutics 33:4, pages 240-246.
Crossref
Carl P. HerbortJr.Jr., Ilknur Tugal-TutkunPiergiorgio NeriCarlos PavésioSumru OnalPhuc LeHoang. (2017) Failure to Integrate Quantitative Measurement Methods of Ocular Inflammation Hampers Clinical Practice and Trials on New Therapies for Posterior Uveitis. Journal of Ocular Pharmacology and Therapeutics 33:4, pages 263-277.
Crossref
Philip Ian Murray & Saaeha Rauz. (2016) The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis. Best Practice & Research Clinical Rheumatology 30:5, pages 802-825.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.